QZS

Software-Aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer

产品代码
QZS
器械名称
Software-Aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 878.1830
FDA 专业组
General, Plastic Surgery
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
1 件
其中 Summary 已存档
0 份,可直接下载
FDA 历史累计 510(k)
1 件(全部年份;本站只收录近三年的明细)

FDA 分类定义

A software-aided adjunctive diagnostic device for use by physicians on lesions suspicious for skin cancer is a prescription device that uses a software algorithm to analyze optical or other physical properties of a skin lesion and returns a classification of the skin lesion. The device is intended for use by a physician not trained in the clinical diagnosis and management of skin cancer as an adjunctive second-read device following identification of a suspicious skin lesion. It is not for use as a standalone diagnostic and is not for use to confirm a clinical diagnosis.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(1 件)

数据窗口为最近三年。最新一件:2024-01-12。

510(k) 号批准日期申请人器械名称摘要
DEN2300082024-01-12Dermasensor, Inc.DermaSensor
FDA 官方分类页: QZS
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。